Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

PRKACA anticorps (AA 18-347)

PRKACA Reactivité: Humain, Souris, Rat, Chien WB, IF Hôte: Souris Monoclonal 5B unconjugated
N° du produit ABIN968292
  • Antigène Voir toutes PRKACA Anticorps
    PRKACA (Protein Kinase A, alpha (PRKACA))
    Épitope
    • 15
    • 10
    • 8
    • 6
    • 6
    • 5
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 18-347
    Reactivité
    • 58
    • 39
    • 15
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    Humain, Souris, Rat, Chien
    Hôte
    • 60
    • 11
    • 2
    • 1
    Souris
    Clonalité
    • 63
    • 11
    Monoclonal
    Conjugué
    • 43
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp PRKACA est non-conjugé
    Application
    • 59
    • 31
    • 17
    • 13
    • 13
    • 13
    • 9
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF)
     Réactivité croisée
    Chien, Rat (Rattus), Souris
    Attributs du produit
    1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
    2. Please refer to us for technical protocols.
    3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
    4. Source of all serum proteins is from USDA inspected abattoirs located in the United States.
    Purification
    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
    Immunogène
    Human PKA[Calpha] subunit aa. 18-347
    Clone
    5B
    Isotype
    IgG2b
    Top Product
    Discover our top product PRKACA Anticorps primaire
  • Commentaires

    Related Products: ABIN968535, ABIN967389

    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    250 μg/mL
    Buffer
    Aqueous buffered solution containing BSA, glycerol, and ≤0.09 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store undiluted at -20°C.
  • DeSouza, Reiken, Ondrias, Yang, Matkovich, Marks: "Protein kinase A and two phosphatases are components of the inositol 1,4,5-trisphosphate receptor macromolecular signaling complex." dans: The Journal of biological chemistry, Vol. 277, Issue 42, pp. 39397-400, (2002) (PubMed).

    Chen, Yu, Lee, Chiang, Chao, Huang, Chiong, Huang, Lai, Yang-Yen, Yen: "CREB is one component of the binding complex of the Ces-2/E2A-HLF binding element and is an integral part of the interleukin-3 survival signal." dans: Molecular and cellular biology, Vol. 21, Issue 14, pp. 4636-46, (2001) (PubMed).

    Orellana, Marfella-Scivittaro: "Distinctive cyclic AMP-dependent protein kinase subunit localization is associated with cyst formation and loss of tubulogenic capacity in Madin-Darby canine kidney cell clones." dans: The Journal of biological chemistry, Vol. 275, Issue 28, pp. 21233-40, (2000) (PubMed).

    Westphal, Soderling, Alto, Langeberg, Scott: "Scar/WAVE-1, a Wiskott-Aldrich syndrome protein, assembles an actin-associated multi-kinase scaffold." dans: The EMBO journal, Vol. 19, Issue 17, pp. 4589-600, (2000) (PubMed).

    Taylor, Buechler, Yonemoto: "cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes." dans: Annual review of biochemistry, Vol. 59, pp. 971-1005, (1990) (PubMed).

  • Antigène
    PRKACA (Protein Kinase A, alpha (PRKACA))
    Autre désignation
    PKA C (PRKACA Produits)
    Synonymes
    anticorps PKACA, anticorps Calpha, anticorps Cs-PKA, anticorps PKCA1, anticorps PKA, anticorps PKCD, anticorps Pkaca, anticorps zgc:158799, anticorps protein kinase cAMP-activated catalytic subunit alpha, anticorps protein kinase, cAMP dependent, catalytic, alpha, anticorps cAMP-dependent protein kinase catalytic subunit, anticorps protein kinase, cAMP-dependent, catalytic, alpha, genome duplicate a, anticorps PRKACA, anticorps Prkaca, anticorps kin-1, anticorps prkacaa
    Sujet
    CAMP-dependent Protein Kinase (PKA) is composed of two distinct subunits: catalytic (C) and regulatory (R). Four regulatory subunits have been identified: RIalpha, RIbeta, RIIalpha, and RIIbeta. These subunits define type I and II cAMP-dependent protein kinases. Following binding of cAMP, the regulatory subunits dissociate from the catalytic subunits, rendering the enzyme active. Type I and type II holoenzymes have three potential C subunits (Calpha, Cbeta, or Cgamma). Type II PKA can be distinguished by autophosphorylation of the R-subunits, while type I PKA binds Mg/ATP with high affinity. The levels of expression of the different subunits vary according to cell and tissue type.
    Poids moléculaire
    40 kDa
    Pathways
    Signalisation NF-kappaB, Signalisation Hedgehog, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Signaling Events mediated by VEGFR1 and VEGFR2, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, VEGFR1 Specific Signals, Lipid Metabolism, SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2
Vous êtes ici:
Support technique